Advertisement

Topics

CutisPharma, Inc. Company Profile

16:35 EDT 20th June 2018 | BioPortfolio

CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST(R) Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Two U.S. patents have been issued to the Company with several additional patents pending.


News Articles [6 Associated News Articles listed on BioPortfolio]

CutisPharma's diarrhea, colitis treatment approved by FDA

CutisPharma's Firvanq, or vancomycin hydrochloride, was approved by the FDA as an oral treatment for patients with Clostridiu -More- 

NovaQuest Capital Management acquires CutisPharma

US privately-held drugmaker CutisPharma today announced that it has been acquired by NovaQuest Capital…

CutisPharma Announces FDA Approval of Firvanq (vancomycin) for Treatment of Clostridium Difficile Associated Diarrhea and Staphylococcus Aureus Colitis

WILMINGTON, Mass. (Jan. 29, 2018) – CutisPharma announced today that the US Food and Drug Administration (FDA) has approved Firvanq (vancomycin hydrochloride) for oral solution, for the treatment of...

FDA approves oral liquid vancomycin formulation from CutisPharma

CutisPharma wins FDA approval of oral liquid vancomycin

The company's version of the antibiotic is designed to reduce the burden on pharmacists who compound the drug into liquid formulations.

Cutispharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryCutispharma Inc Cutispharma is a pharmaceutical company that develops and markets proprietary drug products. The company offers products such as oral solutions, oral suspensions, suppositories,...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

In vitro stability of three oral vancomycin preparations stored at 2- 5ºC and ambient room temperature for up to 60 days against 100 Clostridioides (Clostridium) difficile and 25 Staphylococcus aureus strains.

Oral vancomycin is used to treat Clostridioides (Clostridium) difficile infection. Several different preparations are available including reconstituted IV solutions, vancomycin capsules, and grape fla...

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

CutisPharma, Inc.

CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies...

More Information about "CutisPharma, Inc." on BioPortfolio

We have published hundreds of CutisPharma, Inc. news stories on BioPortfolio along with dozens of CutisPharma, Inc. Clinical Trials and PubMed Articles about CutisPharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CutisPharma, Inc. Companies in our database. You can also find out about relevant CutisPharma, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record